Patents Issued in February 1, 2022
  • Patent number: 11235141
    Abstract: Disclosed are systems and methods for use of an inductive link for a communication channel in a transcutaneous energy transfer system. An example system may include a resonant circuit associated with an external primary, a power transistor connected to the resonant circuit and configured to drive the resonant circuit with a first time-varying electrical signal having a frequency, and a power driver connected to the power transistor that is configured to set the frequency of the first time-varying electrical signal to a resonant frequency to enable power transfer from the external primary to an implanted secondary. The example system may further include a communication driver operatively connected to the power transistor and configured to encode the first time-varying electrical signal with a data signal by modulating an attribute of the time-varying electrical signal as electrical power is transferred from the external primary to the implanted secondary.
    Type: Grant
    Filed: September 9, 2019
    Date of Patent: February 1, 2022
    Assignee: Minnetronix, Inc.
    Inventors: Lori Lucke, Vlad Bluvshtein, James Kurkowski, William Weiss
  • Patent number: 11235142
    Abstract: Apparatus for transcutaneous electrical nerve stimulation in a user, the apparatus comprising: a stimulation unit for electrically stimulating at least one nerve using electrical pulses; an electrode assembly connectable to the stimulation unit, the electrode assembly comprising a sensing unit, a storage unit, and a communications unit; and a control unit connected to the stimulation unit and the communications unit, the control unit being configured for controlling operation of the stimulation unit based on information from the electrode assembly.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: February 1, 2022
    Assignee: NeuroMetrix, Inc.
    Inventors: Shai N. Gozani, Marc P. Cryan, Andres Aguirre, Glenn Herb, Xuan Kong
  • Patent number: 11235143
    Abstract: A WCD system is configured to detect when a therapy administered to a patient by the WCD system is unsuccessful, and in response determine whether to send notifications to remote non-witness responders. The WCD system may be configured to decide to send such notifications after the WCD system determines it has administered a predetermined number of unsuccessful shocks to the patient. The predetermined number of unsuccessful shocks may be the maximum number of unsuccessful shocks the WCD system will administer to a patient, or every Xth shock (e.g., 3rd shock). The WCD system can be configured to periodically resend the notification. The notifications may be in form of SMS, voice messages, emails, app notifications, etc. sent to cell phones, smartphones, computers, laptops, tablets etc. of the responders either directly, via a server, or via a CAD-coupled server.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: February 1, 2022
    Assignee: WEST AFFUM HOLDINGS CORP.
    Inventors: Douglas K. Medema, Steven E. Sjoquist
  • Patent number: 11235144
    Abstract: A system and method for pulsed electromagnetic fields (PEMF) tissue engineering enhances musculoskeletal tissue stimulation. A tissue engineering device may include both low and high pulse frequency signal generation components that may alternatively drive one or more coils to generate PEMFs. These PEMFs may be applied to bone tissue, tendons, ligaments, and/or cartilage. A prescribed treatment regimen using the tissue engineering device may include a first period of time where a first pulse frequency is used in treatment that supports tissue proliferation followed by a second period of time where a second pulse frequency (less than the first pulse frequency) is used in treatment that supports tissue differentiation. A treatment regimen may also include, with the frequency characteristic, applying a slew rate to the pulse characteristics that is on the order of around 30 to 100 Tesla per second to drive tissue differentiation in a targeted manner.
    Type: Grant
    Filed: May 18, 2020
    Date of Patent: February 1, 2022
    Assignee: ORTHOFIX US LLC
    Inventors: James T. Ryaby, Erik Waldorff, Ronald Midura, Maciej Zborowski
  • Patent number: 11235145
    Abstract: Implantable device systems include an electrical lead with one or more electrodes and a shield. The shield is attached to the electrical lead with the shield covering a first side of the electrode and extending laterally away from the electrode. The shield directs energy from at least one of the electrodes of the the electrical lead in a direction away from the shield.
    Type: Grant
    Filed: November 6, 2017
    Date of Patent: February 1, 2022
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventors: Arthur J. Foster, G. Shantanu Reddy
  • Patent number: 11235146
    Abstract: The present disclosure generally relates to a system for treating headaches and other pain associated with the occipital nerves. More particularly, the disclosure relates to a system of treating pain by selectively activating specific nerve fibers with a single, fault-resistant contact situated proximate to, but not in direct contact with, portions of one or more the occipital nerves. Additional measures ensure the lead does not migrate or fracture, resulting in long-lasting pain relief.
    Type: Grant
    Filed: December 10, 2015
    Date of Patent: February 1, 2022
    Assignee: SPR THERAPEUTICS, INC.
    Inventors: Joseph W. Boggs, II, Amorn Wongsarnpigoon
  • Patent number: 11235147
    Abstract: A charge balancing circuit is adapted to be connected to an electrode and to a stimulation source. The charge balancing circuit has an electrode terminal for receiving an electrode voltage, an amplifier coupled to the electrode terminal and adapted to amplify and invert the electrode voltage for generating an intermediate voltage and a compensation stage. The compensation stage is adapted to generate an output current if the electrode voltage lies outside a specified safety range and to generate the output current depending on the intermediate voltage. The compensation stage is further adapted to supply the output current to the electrode terminal for driving the electrode voltage towards and/or into the safety range.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: February 1, 2022
    Assignee: ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG
    Inventors: Natalie Butz, Matthias Kuhl, Yiannos Manoli
  • Patent number: 11235148
    Abstract: Portable transdermal electrical stimulation (TES) applicators for modifying a subject's cognitive state by applying stimulation to the subject's skin. One or more electrode may be on the subject's mastoid, and/or on or near the back of the subject's neck. The portable applicators are configured and adapted to be lightweight and may be wearable, and to deliver a high-intensity TES able to evoke or enhance a predetermined cognitive effect to stimulate either the trigeminal, facial and/or cervical plexus. These TES applicators may include a pair of electrodes and a TES control module comprising a processor, a timer and a waveform generator.
    Type: Grant
    Filed: May 20, 2019
    Date of Patent: February 1, 2022
    Assignee: Thync Global, Inc.
    Inventors: Jonathan D. Charlesworth, Sumon K. Pal, William J. Tyler, Daniel Z. Wetmore, Isy Goldwasser, Alyssa M. Boasso, Hailey M. Mortimore, Rafal Piersiak
  • Patent number: 11235149
    Abstract: Optogenetic signal processing is described for an auditory prosthesis with an intracochlear array of optical stimulation sources implanted in a patient having auditory neurons genetically modified with light sensitive ion channels. Stimulation timing signals are generated for the corresponding auditory neurons for each band pass signal based on characteristic temporal fine structure features of the band pass signals. The stimulation timing signals include: i. one or more channel opening signals adapted to open the ion channels of the corresponding auditory neurons, and ii. one or more channel closing signals adapted to close the ion channels of the corresponding ion channels. Optical stimulation signals are then produced for the optical stimulation sources based on the stimulation timing signals.
    Type: Grant
    Filed: April 13, 2017
    Date of Patent: February 1, 2022
    Assignee: MED-EL Elektromedizinische Geraete GmbH
    Inventors: Dirk Meister, Darshan Shah
  • Patent number: 11235150
    Abstract: A cochlear implant, for use with a micro camera, including a stimulation assembly, a cochlear lead with an electrode array, a lens associated with the distal region of the electrode array, an optical fiber bundle that extends proximally from the lens and outwardly from the proximal region of the cochlear lead, a camera interface in which the proximal end of the optical fiber bundle is located and that is configured to receive the micro camera, and at least one illumination guide that extends from the camera interface to the cochlear lead.
    Type: Grant
    Filed: March 6, 2019
    Date of Patent: February 1, 2022
    Assignee: Advanced Bionics AG
    Inventors: Martin Grossoehmichen, Konstantin Silberzahn, Tim Nauwelaers, Volkmar Hamacher
  • Patent number: 11235151
    Abstract: The present invention is a method of processing a video image in an electronic video processor, including the steps of receiving an input image having an input field of view, generating a processed image from the input image, and having an output field of view smaller than the input field of view, searching for a predetermined pattern within the input image, providing an indication when the predetermined pattern is found in the input image, zooming the processed image to the input field of view and highlighting the predetermined pattern in the processed image in response to the indication.
    Type: Grant
    Filed: July 23, 2019
    Date of Patent: February 1, 2022
    Assignee: Second Sight Medical Products, Inc
    Inventors: Robert J Greenberg, Avraham I Caspi, Francesco Merlini, Arup Roy
  • Patent number: 11235152
    Abstract: One aspect of the invention provides a computer-implemented method of conveying a visual image to a blind subject fitted with a visual prosthesis. The computer-implemented method includes: mapping a representation of a visual image onto a two-dimensional array of points having a resolution greater than or equal to an electrode resolution of the visual prosthesis; identifying one or more continuous paths along the mapped representation; and controlling the visual prosthesis to sequentially actuate electrodes along the one or more paths. Another aspect of the invention provides a system including: a visual prosthesis comprising multiple electrodes; and an imaging processing device in communication with the visual prosthesis. The imaging processing device can be programmed to receive an image and perform any of the methods described herein.
    Type: Grant
    Filed: March 5, 2019
    Date of Patent: February 1, 2022
    Assignee: Baylor College of Medicine
    Inventors: Michael S. Beauchamp, Daniel Yoshor, William H. Bosking, III
  • Patent number: 11235153
    Abstract: A medical device for electrical stimulation of a patient. A pulse generator generates current pulses for the electrical stimulation. An electrode lead with a plurality of electrode contacts delivers the pulses to tissue of the patient. The pulse generator repeatedly delivers a current pulse between two electrodes forming a first group and delivers a charge balancing current pulse after each current pulse between the electrodes of the first group. The respective current pulse is separated from the succeeding charge balancing current pulse by an inter pulse interval. The respective current pulse has an amplitude with the same absolute magnitude as the succeeding charge balancing current pulse, but is of opposite sign. The pulse generator delivers between each current pulse and the succeeding charge balancing current pulse a current pulse between two further electrodes forming a second group of electrode contacts of the plurality of electrode contacts.
    Type: Grant
    Filed: October 17, 2019
    Date of Patent: February 1, 2022
    Assignee: BIOTRONIK SE & Co. KG
    Inventors: Andrew B. Kibler, Sean Slee, Pamela Shamsie Victoria Riahi
  • Patent number: 11235154
    Abstract: A device and algorithm for controlling an autonomic function in an individual. In particular, a controller device that utilizes physiological measurements (such as blood pressure) to regulate spinal cord electrical stimulation to stabilize blood pressure. A control interface and algorithm for controlling an autonomic function in a subject. In particular, an algorithm that utilizes physiological measurements (such as blood pressure) to regulate spinal cord electrical stimulation to stabilize blood pressure.
    Type: Grant
    Filed: February 16, 2018
    Date of Patent: February 1, 2022
    Assignee: THE UNIVERSITY OF BRITISH COLUMBIA
    Inventors: Aaron Phillips, Andrei Krassioukov, Jordan Squair
  • Patent number: 11235155
    Abstract: An example of a neurostimulation system may include a storage device, a programming control circuit, and a graphical user interface (GUI). The storage device may be configured to store individually definable waveforms. The programming control circuit may be configured to generate stimulation parameters controlling the delivery of the neurostimulation pulses according to a pattern. The GUI may be configured to define the pattern using one or more waveforms selected from the individually definable waveforms. The GUI may display waveform tags each selectable for access to a waveform of the individually definable waveforms, and display a waveform builder in response to selection of one of the waveform tags. The waveform builder may present a graphical representation of the accessed waveform and allow for the accessed waveform to be adjusted by editing the graphical representation of the accessed waveform on the GUI.
    Type: Grant
    Filed: September 23, 2019
    Date of Patent: February 1, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Michael A. Moffitt, Sridhar Kothandaraman
  • Patent number: 11235156
    Abstract: A method of providing vagus nerve stimulation (VNS) to a user is provided. The method includes the steps of: (1) collecting, by one or more sensors monitoring a user, one or more sets of physiological data; (2) determining, by a controller, an occurrence of a physiological event based on the one or more sets of physiological data; (3) stimulating, by a first earpiece worn by a user, a vagus nerve of the user with a VNS signal generated based on the controller determining the occurrence of the physiological event, wherein the VNS signal has an amplitude. The physiological condition may be an anxiety attack. The physiological condition may be a migraine headache.
    Type: Grant
    Filed: September 11, 2019
    Date of Patent: February 1, 2022
    Assignee: Bose Corporation
    Inventors: Stephen L. Romine, John Trotter
  • Patent number: 11235157
    Abstract: Systems and methods for monitoring and treating patients with heart failure are discussed. The system can store in a memory stimulation parameters, including stimulation timing parameters for a plurality of heart rate ranges. The system includes a plurality of timers with respective durations for the plurality of heart rate ranges. A stimulation control circuit can identify a target heart range in which a detected heart rate falls, and measure an atrioventricular (AV) conduction characteristic value in response to the timer for the target heart range being expired at the detected heart rate. The stimulation control circuit can update a stimulation parameter corresponding to the target heart rate range using the measured AV conduction characteristic. The updated stimulation parameter can be used in cardiac stimulation.
    Type: Grant
    Filed: November 25, 2019
    Date of Patent: February 1, 2022
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Qi An, Yinghong Yu, Adam MacEwen
  • Patent number: 11235158
    Abstract: Systems and methods are provided for detecting arrhythmias in cardiac activity is provided. The systems and methods include measuring conduction delays between an atria (A) and multiple left ventricular (LV) electrodes to obtain multiple intrinsic A/LV intervals, measuring conduction delays between a right ventricular (RV) and the multiple LV electrodes to obtain multiple intrinsic VV intervals. The systems and methods include calculating a first atrial ventricular (AV) delay based on at least one of the intrinsic A/LV intervals, and calculating a second AV delay based on at least one of the intrinsic VV intervals. The systems and methods include selecting a biventricular (BiV) pacing mode or an LV only pacing mode based on a relation between the first and second AV delays, and delivering a pacing therapy based on the selecting operation.
    Type: Grant
    Filed: September 11, 2018
    Date of Patent: February 1, 2022
    Assignee: PACESETTER, INC.
    Inventors: Jan O. Mangual-Soto, Nima Badie, Luke C. McSpadden, Jong Gill, Louis-Philippe Richer
  • Patent number: 11235159
    Abstract: VfA cardiac therapy uses an implantable medical device or system. The implantable medical device includes a tissue-piercing electrode implanted in the basal and/or septal region of the left ventricular myocardium of the patient's heart from the triangle of Koch region of the right atrium through the right atrial endocardium and central fibrous body. The device may include a right atrial electrode, a right atrial motion detector, or both. The device may be implanted completely within the patient's heart or may use one or more leads to implant electrodes in the patient's heart. The device may be used to provide cardiac therapy, including single or multiple chamber pacing, atrioventricular synchronous pacing, asynchronous pacing, triggered pacing, cardiac resynchronization pacing, or tachycardia-related therapy. A separate medical device may be used to provide some functionality for cardiac therapy, such as sensing, pacing, or shock therapy.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: February 1, 2022
    Assignee: Medtronic, Inc.
    Inventors: Zhongping Yang, Thomas A. Anderson, Brian P. Colin, William J. Clemens, Subham Ghosh, Jeffrey M. Gillberg, Maurice T. I. Verbeek, Toine Camps, Lilian Kornet, Berthold Stegemann, Jean Rutten
  • Patent number: 11235160
    Abstract: A connector block that permits simultaneous and continuous interconnection of the three leads of the epicardial pacing wires, the pacemaker, and the ECG monitor on clear separately labeled connectors is provided. Circuitry is provided that allows the display of epicardial signals on the telemetry unit, while still preserving the ability to pace the heart from the pacemaker. When pacing the connector block prevents excessive loading of the pacer signals by the ECG monitor and/or damage to the monitor by the high-voltage pacer signals. The connector block may be used universally on all monitors without the need for sophisticated understanding of the electrical characteristics of the ECG monitor or concern for damage or improper signal loading.
    Type: Grant
    Filed: November 7, 2019
    Date of Patent: February 1, 2022
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Nicholas Von Bergen, Philip Terrien, Matthew Knoespel, Connor Sheedy, James Olson, Randal Mills
  • Patent number: 11235161
    Abstract: Ventricle-from-atrium (VfA) cardiac therapy may utilize a tissue-piercing electrode implanted in the left ventricular myocardium of the patient's heart from the right atrium through the right atrial endocardium and central fibrous body. The exemplary devices and methods may determine whether the tissue-piercing electrode is achieving effective left ventricular capture. Additionally, one or more pacing parameters, or paced settings, may be adjusted in view of the effective left ventricular capture determination.
    Type: Grant
    Filed: September 26, 2019
    Date of Patent: February 1, 2022
    Assignee: Medtronic, Inc.
    Inventor: Subham Ghosh
  • Patent number: 11235162
    Abstract: A system, such as an IMD system, includes a tissue conductance communication (TCC) transmitter configured to generate a beacon signal by generating a carrier signal and modulating a first property of the carrier signal according to a first type of modulation. The TCC transmitter is configured to generate a data signal subsequent to the beacon signal by generating the carrier signal and modulating a second property of the carrier signal different than the first property according to a second type of modulation different than the first type of modulation.
    Type: Grant
    Filed: November 29, 2018
    Date of Patent: February 1, 2022
    Assignee: Medtronic, Inc.
    Inventors: James D. Reinke, Joel B. Artmann, Michael T. Hemming, David J. Peichel, Jonathan P. Roberts, Michael B. Terry, Eric R. Williams
  • Patent number: 11235163
    Abstract: An implantable medical device (IMD) with a receiver having a higher power mode and a lower power mode. In the higher power mode, the receiver can receive a communication from an external device and pass the received communication to a controller, and in the lower power mode the receiver may not receive the communication from the external device and pass the received communication to the controller. In some cases, the IMD may include a physiological sensor providing an output to the controller, and the controller may control whether the receiver is in the higher power mode or the lower power mode based at least in part on the output of the physiological sensor.
    Type: Grant
    Filed: September 18, 2018
    Date of Patent: February 1, 2022
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventors: Paul Huelskamp, Robert D. Brock, II, Brian L. Schmidt
  • Patent number: 11235164
    Abstract: The invention relates to a shape-adaptive medical implant having at least one actuator, which the implant can be changed from a first implant geometry to a second implant geometry, the implant having a different geometric shape in the second implant geometry from that in the first implant geometry, wherein the actuator has a swellable chemical substance which swells when supplied with liquid, and wherein the implant which is designed to supply liquid present outside the implant to the swellable chemical substance. The invention also relates to the use of an electrical signal source.
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: February 1, 2022
    Assignee: MEDIZINISCHE HOCHSCHULE HANNOVER
    Inventors: Jan Stieghorst, Theodor Doll
  • Patent number: 11235165
    Abstract: Described herein are implantable medical devices (IMDs), and methods for use therewith, that enable monitoring of impedance associated with a pathway (e.g., including a lead) used to selectively deliver stimulation pulses to patient tissue. A method involves measuring or storing a first voltage indicative of the energy stored on a reservoir capacitor (Cres) just prior to a stimulation pulse being delivered via the pathway, as well as measuring or storing a second voltage indicative of the energy stored on the Cres just after the stimulation pulse is delivered via the pathway. The method also includes monitoring the impedance associated with the pathway based on a difference between the first and second voltages, which may involve determining a count value indicative of how long it takes to discharge the first voltage to drop to the second voltage, wherein the count value is a surrogate of the impedance associated with the pathway.
    Type: Grant
    Filed: February 4, 2019
    Date of Patent: February 1, 2022
    Assignee: Pacesetter, Inc.
    Inventors: Eric C. Labbe, Paul F. Illegems, Cliff C. Nixon
  • Patent number: 11235166
    Abstract: Disclosed is a transcranial magnetic stimulation treatment apparatus applicable to the technical field of medical devices, comprising a TMS coil, a support, a mechanical arm, a controller, and a positioning device. The positioning device detects the position of a human head and the TMS coil and sends positional information to the controller; the controller controls six driving mechanisms of the mechanical arm to rotate to a corresponding angle. Because the mechanical arm has six degrees of freedom, the TMS coil is capable of stimulating each cerebral region of the brain, and the positioning device is capable of detecting an accurate position of the human head, thereby controlling the mechanical arm to accurately position the TMS coil on the human head, and to reduce manual operation.
    Type: Grant
    Filed: March 12, 2018
    Date of Patent: February 1, 2022
    Assignees: SHENZHEN HANIX UNITED, LTD., SHENZHEN MILEBOT ROBOTICS CO., LTD.
    Inventors: Gong Chen, Jing Ye, Feng Xu, Jialin Feng, Guang Hu
  • Patent number: 11235167
    Abstract: A method of administering light treatment to a biological surface comprising administering light therapy from one or more light sources and administering distraction stimulus from one or more distraction mechanisms. The distraction stimulus is configured to distract a user from a discomfort caused by the light therapy.
    Type: Grant
    Filed: April 30, 2020
    Date of Patent: February 1, 2022
    Assignee: L'Oreal
    Inventor: Lily Truong
  • Patent number: 11235168
    Abstract: This invention relates to a method of photodynamic therapy (PDT) for bladder cancer and its use as an adjuvant or neoadjuvant therapy in the treatment of bladder cancer. The invention provides a composition comprising hexyl 5-ALA ester (HAL) or a pharmaceutically acceptable salt thereof for use in a method of photodynamic therapy for bladder cancer, wherein said composition is instilled into the bladder of a patient in need of such treatment and the inside of said bladder is exposed to blue light having a fluence rate of 1.5 to 12.5 mW/cm2.
    Type: Grant
    Filed: December 19, 2016
    Date of Patent: February 1, 2022
    Assignee: PHOTOCURE ASA
    Inventors: Kjetil Hestdal, Aslak Godal
  • Patent number: 11235169
    Abstract: An Illumination device (100) for photodynamic therapy is provided, the illumination device comprising at least one electromagnetic radiation emitting unit (10), the at least one electromagnetic radiation emitting unit comprising at least one electromagnetic radiation source (1), the electromagnetic radiation source being configured to generate radiation for the irradiation of a region of an irradiation object in an illumination session, wherein the irradiation object is to be arranged at a predetermined object location (300), wherein the predetermined object location is arranged at a distance relative to a radiation output area (11) of the radiation emitting unit through which the radiation generated by the at least one electromagnetic radiation source exits the radiation emitting unit during operation of the illumination device (100).
    Type: Grant
    Filed: March 29, 2021
    Date of Patent: February 1, 2022
    Assignee: BIOFRONTERA PHARMA GMBH
    Inventors: Markus Osterloh, Ben Novak, Hermann Lübbert
  • Patent number: 11235170
    Abstract: A phototherapy device including: an irradiation probe for radiating irradiation light toward a living body; a probe fixing unit into which the irradiation probe is inserted and at the same time fixed on a living body; an observation module placed on the probe fixing unit and provided with an observation means for observing an irradiation site irradiated with irradiation light which is radiated to the living body; and a moving means capable of moving the observation module to a space where the irradiation probe is to be placed in the probe fixing unit during observation of the irradiation site.
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: February 1, 2022
    Assignee: Teijin Pharma Limited
    Inventors: Yuki Kawase, Takamitsu Okayama, Daisuke Niwa, Rei Tamiya, Shosaku Motohara, Satoshi Igarashi
  • Patent number: 11235171
    Abstract: Systems, devices, and methods for non-Gaussian energy distribution modeling for treatment planning algorithms used in particle radiation therapy.
    Type: Grant
    Filed: March 28, 2017
    Date of Patent: February 1, 2022
    Assignee: VARIAN MEDICAL SYSTEMS PARTICLE THERAPY GMBH & CO. KG
    Inventor: Joerg Wulff
  • Patent number: 11235172
    Abstract: A control circuit carries out various actions to facilitate speedy user interaction involving adjustments to radiation dosing that corresponds to a particular mixed radiation treatment plan. These actions can include remixing particular multi-criteria optimization radiation treatment plans.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: February 1, 2022
    Assignee: Varian Medical Systems, Inc.
    Inventor: Kenneth B. Thornton
  • Patent number: 11235173
    Abstract: A radiation beam intensity modulation device constituted of: a control circuitry; a plurality of cells, each of the plurality of cells arranged, responsive to the control circuitry, to be switched between an attenuating state and a transparent state; and attenuating material, each of the plurality of cells arranged to contain therewithin a portion of the attenuating material when in the attenuating state and not contain therewithin the portion of the attenuating material when in the transparent state.
    Type: Grant
    Filed: March 7, 2018
    Date of Patent: February 1, 2022
    Inventors: Yossi Haran, Sigal Sela
  • Patent number: 11235174
    Abstract: Device including a multileaf collimator, the multileaf collimator including an array of leaves and slits, the array having an alternation of leaves and slits and extending in a longitudinal direction, the longitudinal direction being defined as a direction extending from an entrance plane of the array toward an exit plane of the array, each leaf being located between two slits; the device having a source for emitting an incident electromagnetic beam or a source for emitting an incident beam of subatomic particles, the source being arranged to emit the beam in the direction of the entrance plane of the array, the multileaf collimator being arranged to obtain an arrangement of beams from the incident beam, and the arrangement of beams forms an alternation of high-energy lines and lower-energy lines.
    Type: Grant
    Filed: November 2, 2017
    Date of Patent: February 1, 2022
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS-SUD, UNIVERSITE PARIS DIDEROT
    Inventors: Yolanda Prezado, Morgane Dos Santos, Batiste Janvier
  • Patent number: 11235175
    Abstract: A method and apparatus to automatically control the timing of an image acquisition by an imaging system in developing a correlation model of movement of a target within a patient.
    Type: Grant
    Filed: January 8, 2016
    Date of Patent: February 1, 2022
    Assignee: Accuray Incorporated
    Inventors: Shutian Li, Ye Sheng, Sohail Sayed
  • Patent number: 11235176
    Abstract: Subject positioning systems and methods are provided. A method may include obtaining first information of at least part of a subject when the subject is located at a preset position, and determining, based on the first information, a first position of each of one or more feature points located on the at least part of the subject. The method may include obtaining, using an imaging device, second information of the at least part of the subject when the subject is located at a candidate position. The method may further include determining, based on the second information, a second position of each of the one or more feature points, a first distance between the first position and the second position for each feature point of the one or more feature points, and a target position of the subject based at least in part on the one or more first distances.
    Type: Grant
    Filed: December 29, 2019
    Date of Patent: February 1, 2022
    Assignee: SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.
    Inventors: Yifeng Wang, Yige Zhang
  • Patent number: 11235177
    Abstract: The present invention relates to advanced Cherenkov-based imaging systems, tools, and methods of feedback control, temporal control sequence image capture, and quantification in high resolution dose images. In particular, the present invention provides a system and method for simple, accurate, quick, robust, real-time, water-equivalent characterization of beams from LINACs and other systems producing external-therapy radiation for purposes including optimization, commissioning, routine quality auditing, R&D, and manufacture. The present invention also provides a system and method for rapid and economic characterization of complex radiation treatment plans prior to patient exposure. Further, the present invention also provides a system and method of economically detecting Cherenkov radiation emitted by tissue and other media in real-world clinical settings (e.g., settings illuminated by visible light).
    Type: Grant
    Filed: October 23, 2017
    Date of Patent: February 1, 2022
    Assignee: DoseOptics LLC
    Inventors: Venkataramanan Krishnaswamy, Brian W. Pogue
  • Patent number: 11235178
    Abstract: Embodiments of the present disclosure relate to techniques for facilitating personalized neuromodulation treatment protocols. In one embodiment, a predetermined treatment position of an energy application device is used to guide future treatments for the patient. In one embodiment, a position of the energy application device relative to the predetermined treatment position is determined. In one embodiment, a total dose of ultrasound energy applied to the region of interest is determined.
    Type: Grant
    Filed: September 4, 2018
    Date of Patent: February 1, 2022
    Assignee: GENERAL ELECTRIC COMPANY
    Inventors: Christopher Michael Puleo, Yang Zhao, Kirk Dennis Wallace, Ying Fan, Jeffrey Michael Ashe, David Andrew Shoudy
  • Patent number: 11235179
    Abstract: A method and system for energy-based (e.g., ultrasound treatment and/or other modalities) of skin glands are provided. An exemplary method and system for targeted treatment of skin glands, such as sweat and/or sebaceous glands, can be configured in various manners, such as through use of therapy only, therapy and monitoring, imaging and therapy, or therapy, imaging, and monitoring, and/or through use of focused, unfocused, or defocused ultrasound (or other energy) through control of various spatial and temporal parameters. As a result, ablative energy can be deposited at the particular depth at which the skin gland population is located below the skin surface.
    Type: Grant
    Filed: March 23, 2021
    Date of Patent: February 1, 2022
    Assignee: Guided Therapy Systems, LLC
    Inventors: Peter G. Barthe, Michael H. Slayton, Inder Raj S. Makin
  • Patent number: 11235180
    Abstract: A method and system for noninvasive face lifts and deep tissue tightening are disclosed. An exemplary method and treatment system are configured for the imaging, monitoring, and thermal injury to treat the SMAS region. In accordance with an exemplary embodiment, the exemplary method and system are configured for treating the SMAS region by first, imaging of the region of interest for localization of the treatment area and surrounding structures, second, delivery of ultrasound energy at a depth, distribution, timing, and energy level to achieve the desired therapeutic effect, and third to monitor the treatment area before, during, and after therapy to plan and assess the results and/or provide feedback.
    Type: Grant
    Filed: March 23, 2021
    Date of Patent: February 1, 2022
    Assignee: Guided Therapy Systems, LLC
    Inventors: Michael H. Slayton, Peter G. Barthe, Inder Raj S. Makin, Brian D. O'Connor
  • Patent number: 11235181
    Abstract: In an example, a respirator includes a respirator body having a distal portion and a proximal portion, the distal portion including a filter housing wall and an open distal end. The proximal portion includes a facial interface which is compliant and deformable from an undeformed state to a deformed state to conform to a facial contour of an individual. One or more filter frames are inserted into the distal portion and supported by the filter housing wall to separate filter media on opposite sides of at least one of the one or more filter frames. A filter cover is releasably attached to the open distal end to enclose the one or more filter frames and filter media, forming a filter housing. The one or more filter frames are removable from the distal portion and replaced into the distal portion to allow replacement of the filter media.
    Type: Grant
    Filed: November 12, 2020
    Date of Patent: February 1, 2022
    Assignee: The Government of the United States of America, as represented by the Secretary of Homeland Security
    Inventors: Michael Daeffler, Michael Plumley, Ronald Adrezin
  • Patent number: 11235182
    Abstract: Embodiments relate generally to methods and systems for detecting and indicating end-of-service-life in disposable filtration masks. Applicant has proposed incorporating end-of-service-life indicators comprising color changing chemicals into the mask. The indicating chemicals may be incorporated into the nonwoven fabric material of the mask, or may be attached to the nonwoven material of the mask, such as by dipping, spraying, or adhering. The color change of the indicating chemicals may indicate to a user that the use life of the mask has been depleted.
    Type: Grant
    Filed: September 5, 2014
    Date of Patent: February 1, 2022
    Assignee: Honeywell International Inc.
    Inventors: Li Wang, Xiang Zhu, Yuzheng Lu
  • Patent number: 11235183
    Abstract: A wearable device for comprehensive bio-monitoring of physiologic metrics to determine metabolic, pulmonary and cardiac function and oxygen saturation measurements from breathing mask apparatuses. The device non-invasively monitors the physiologic profile of the subject, and is capable of detecting physiologic changes, predicting onset of symptoms, and alerting the wearer or another person or system. In some embodiments, the device comprises both a wearable sensor suite and a portable gas composition and flow analysis system. In preferred embodiments, it comprises a miniaturized non-invasive sensor suite for detecting physiologic changes to detect dangerous breathing or other health conditions. The acquired physiologic profile is used to generate alarms or warnings based on detectable physiological changes, to adjust gas delivery to the subject, alter mission profiles, or to transfer control of the craft or other duties away from a debilitated subject.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: February 1, 2022
    Assignee: Orbital Research Inc.
    Inventors: David Dashevsky, Matthew Birch, Aaron T. Rood, Frederick J. Lisy
  • Patent number: 11235184
    Abstract: An intranasal cannula apparatus for use to filter air that enters a nasal cavity of a user is provided. The apparatus includes a pair of elongated bodies coupled together and designed to insert in the nasal cavity of the user. Each elongated body has a front portion, a rear portion, a top portion, a bottom portion and side portions that form an internal cavity therein. Each elongated body has a nasal opening disposed on the bottom portion of the elongated body that aligns with one of the nostrils of the user. A dorsal opening is disposed on the top portion of each elongated body. A pair of filters is disposed within the pair of elongated bodies. The apparatus is designed to permit air from the nostrils of the user to pass entirely through the nasal openings and dorsal openings in the elongated bodies to the nasal cavity of the user.
    Type: Grant
    Filed: February 24, 2020
    Date of Patent: February 1, 2022
    Inventors: Gregory Gary Caputy, Jordan Jon Carlo Caputy
  • Patent number: 11235185
    Abstract: A system and method for detecting securement of a proximity lanyard system to a bucket anchor in a bucket having a proximity sensor positioned therein. The proximity lanyard system can include an elongated body portion having a first end and a second end; a harness attachment positioned at the first end of the body portion; an anchor attachment positioned at the second end of the body portion; and a sensor substrate section comprising a sensor substrate and being integrated with the second end of the flexible body portion. The proximity sensor can detect the sensor substrate when the anchor attachment is connected to the bucket anchor.
    Type: Grant
    Filed: August 9, 2018
    Date of Patent: February 1, 2022
    Assignee: Buckingham Manufacturing Company, Inc.
    Inventor: Kevin Truesdell
  • Patent number: 11235186
    Abstract: Techniques and safety devices are described for extinguishing fires within an inventory management system. A plurality of fire extinguishing devices for a plurality of containers in an inventory management system is monitored. Upon determining that a fire condition is occurring within the inventory management system, a positional information data store is queried to determine a current position of a first container within the inventory management system. Two or more containers within the inventory management system that are in close proximity to the first container are identified and one or more wireless signals are transmitted to two or more fire extinguishing devices of the plurality of fire extinguishing devices that are contained within the two or more containers, to activate the two or more first extinguishing devices. The plurality of containers is scanned using an infrared scanning device to determine whether all fire conditions within the inventory management system are extinguished.
    Type: Grant
    Filed: February 8, 2021
    Date of Patent: February 1, 2022
    Assignee: Amazon Technologies, Inc.
    Inventor: William Scott Kalm
  • Patent number: 11235187
    Abstract: A method for detecting an event in or around a building. The method includes recording a baseline signal characteristic that characterizes a wireless signal transmitted between devices in or around the building during a baseline time period and recording a second signal characteristic that characterizes the wireless signal during a second time period after the baseline time period. An event in or around the building is detected in response to a determination that the second signal characteristic is abnormal relative to the baseline signal characteristic, the event degrading the wireless signal during the second time period. An alarm is triggered in response to detecting the event.
    Type: Grant
    Filed: February 26, 2020
    Date of Patent: February 1, 2022
    Assignee: Johnson Controls Tyco IP Holdings LLP
    Inventors: Craig E. Trivelpiece, Robert C. Hall, Jr., Timothy C. Gamroth
  • Patent number: 11235188
    Abstract: A mobile exercise device (1) having a plurality of exercise equipment modules (2, 3, 4). Each said module including a frame (7, 8, 9) defining a space (10, 11, 12) adapted to receive exercise equipment. A plurality of mounting means (46) locatable on said frames to connect said modules together. A plurality of indicators (30) operatively associated with said modules and adapted in use to direct a user and/or trainer to the equipment to use for a particular exercise routine.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: February 1, 2022
    Assignee: F45 TRAINING PTY LTD
    Inventor: Adam Gilchrist
  • Patent number: 11235189
    Abstract: A weight plate gap adjustment module for weight training equipment includes an elastic member located at the topmost weight plate of the weight training equipment and having a supporting portion arranged on the weight plate adjacent to the topmost weight plate, and an adjustment member set on the topmost weight plate and movable toward the elastic member to increase the elastic force of the elastic member, so that when the elastic force of the elastic member is greater than the total weight of the topmost weight plate and the traction shaft, the elastic force of the elastic member drives the elastic member to push the topmost weight plate and the traction shaft to move relative to the other weight plates, allowing the locking pin to be selectively inserted through one weight plate and the traction shaft and joined to the traction shaft.
    Type: Grant
    Filed: September 28, 2020
    Date of Patent: February 1, 2022
    Assignee: HEALTHSTREAM TAIWAN INC.
    Inventor: Chun-Ting Chen
  • Patent number: 11235190
    Abstract: An information related to the position of an actuator coupled to a cable which is coupled to a motor is received. A filter is used to provide an input to a motor controller coupled to the motor, to adjust torque on the motor such that a strength curve is implemented relative to the position of the actuator.
    Type: Grant
    Filed: February 18, 2021
    Date of Patent: February 1, 2022
    Assignee: Tonal Systems, Inc.
    Inventors: Aly E. Orady, Bret G. Stott